Open study of quadrivalent VN-100 in Japanese healthy volunteers

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222562

Enrollment

150

Registered

2014-07-23

Start date

2014-10-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis of influenza infection

Interventions

investigational material(s) Generic name etc : VN-100 (intradermal vaccine for seasonal influenza) INN of investigational material : - Therapeutic category code : 631 Vaccines Dosage and Administratio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Japanese healthy volunteers

Exclusion criteria

Exclusion criteria: 1) Subjects with history of seasonal influenza in the past 6 months 2) Subjects with history of seasonal influenza vaccination in the past 6 months

Design outcomes

Primary

Measure	Time frame
safety efficacy 1) Safety endpoints: adverse events, laboratory values and body temperature 2) Immunology endpoints: HI antibody titer, SRH antibody titer and neutralizing antibody titer	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026